Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation

Reuven Or, Aliza Ackerstein, Arnon Nagler, Avraham Amar, Elizabeth Naparstek, Gabor Varadi, Joseph Kapelushnik, Simcha Samuel, Thea Pugatsch, Chaim Brautbar, Shimon Slavin

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences